ChemoCentryx
CCXI
#3563
Rank
A$5.66 B
Marketcap
A$78.70
Share price
0.00%
Change (1 day)
25.63%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: A$5.66 Billion

On November 25, 2022 ChemoCentryx had a market cap of A$5.66 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022A$5.49 B56.22%
2021A$3.51 B-36.89%
2020A$5.57 B63.79%
2019A$3.40 B333.76%
2018A$0.78 B111.06%
2017A$0.37 B-24.27%
2016A$0.49 B-0.11%
2015A$0.49 B35.5%
2014A$0.36 B30.24%
2013A$0.27 B-27.26%
2012A$0.38 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Biogen
BIIB
A$37.73 B 566.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$596.14 B 10,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$149.03 B 2,532.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
A$164.34 B 2,803.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$759.74 B 13,322.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$264.45 B 4,572.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$215.51 B 3,707.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$52.65 B 830.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
A$380.72 B 6,626.26%๐Ÿ‡บ๐Ÿ‡ธ USA